Treatment of aromatase inhibitor therapy-related osteoporosis

Details for Australian Patent Application No. 2005206137 (hide)

Owner Wyeth

Inventors Boudes, Pol; Jenkins, Simon N.; Sherman, Matthew L.; Komm, Barry S.; Frost, Philip

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005206137

PCT Pub. Number WO2005/070434

Priority 60/536,035 13.01.04 US

Filing date 11 January 2005

Wipo publication date 4 August 2005

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/4184 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/566 (2006.01) - having an oxo group in position 17, e.g. oestrone

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070434 Priority application(s): WO2005/070434

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206139-Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss

2005206135-Method of treating razor blade cutting edges